Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Noble Romans (NROM) Liabilities and Shareholders Equity (2016 - 2025)

Noble Romans (NROM) has 15 years of Liabilities and Shareholders Equity data on record, last reported at $16.1 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 4.53% year-over-year to $16.1 million; the TTM value through Sep 2025 reached $65.4 million, down 7.52%, while the annual FY2024 figure was $16.8 million, 9.26% down from the prior year.
  • Liabilities and Shareholders Equity reached $16.1 million in Q3 2025 per NROM's latest filing, down from $16.2 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $19.4 million in Q4 2021 and bottomed at $16.1 million in Q3 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $18.1 million, with a median of $18.5 million recorded in 2023.
  • The widest YoY moves for Liabilities and Shareholders Equity: up 5.21% in 2021, down 16.61% in 2021.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $19.4 million in 2021, then fell by 5.33% to $18.3 million in 2022, then increased by 0.74% to $18.5 million in 2023, then decreased by 9.26% to $16.8 million in 2024, then decreased by 4.09% to $16.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $16.1 million in Q3 2025, $16.2 million in Q2 2025, and $16.3 million in Q1 2025.